Morpholino

MO2-mir7a-2

ID
ZDB-MRPHLNO-201005-3
Name
MO2-mir7a-2
Previous Names
  • loop 7a MO-2 (1)
Target
Sequence
5' - TGTTGTCAGTACTGATGACGTCACA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-mir7a-2
No data available
Phenotype
Phenotype resulting from MO2-mir7a-2
No data available
Phenotype of all Fish created by or utilizing MO2-mir7a-2
Phenotype Fish Conditions Figures
brain GFP expression increased amount, abnormal ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 6 with image from Adusumilli et al., 2020
diencephalon Wnt signaling pathway increased occurrence, abnormal ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 3 with image from Adusumilli et al., 2020
brain th expression increased amount, abnormal ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 6 with image from Adusumilli et al., 2020
caudal tuberculum ventral region GFP expression increased amount, abnormal ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 3 with image from Adusumilli et al., 2020
diencephalon GFP expression increased amount, abnormal ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 3 with image from Adusumilli et al., 2020
hypothalamus GFP expression increased amount, abnormal ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 3 with image from Adusumilli et al., 2020
diencephalon id3 expression increased amount, abnormal ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 3 with image from Adusumilli et al., 2020
diencephalon nr4a2a expression increased amount, abnormal ia5Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Fig. S5 from Adusumilli et al., 2020
diencephalon lmx1bb expression increased amount, abnormal ia5Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Fig. S5 from Adusumilli et al., 2020
diencephalon mCherry expression increased amount, abnormal ia5Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Fig. S5 from Adusumilli et al., 2020
diencephalon EGFP expression decreased amount, abnormal vu12Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 8 with image from Adusumilli et al., 2020
telencephalon EGFP expression decreased amount, abnormal vu12Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 8 with image from Adusumilli et al., 2020
hindbrain EGFP expression decreased amount, abnormal vu12Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 8 with image from Adusumilli et al., 2020
telencephalon diencephalon boundary smoothened signaling pathway decreased occurrence, abnormal nu15Tg; y1Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 8 with image from Adusumilli et al., 2020
brain smoothened signaling pathway decreased occurrence, abnormal nu15Tg; y1Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 8 with image from Adusumilli et al., 2020
forebrain midbrain boundary smoothened signaling pathway decreased occurrence, abnormal nu15Tg; y1Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 8 with image from Adusumilli et al., 2020
hypothalamus smoothened signaling pathway decreased occurrence, abnormal nu15Tg; y1Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3 standard conditions Figure 8 with image from Adusumilli et al., 2020
Citations